Diabetes treatment is constantly progressing, with new therapeutic options emerging to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://junaidmgqs736688.gynoblog.com/37914788/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment